# HIV Drug Resistance Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil

> **NCT04453436** · — · ACTIVE_NOT_RECRUITING · sponsor: **Federal University of São Paulo** · enrollment: 2500 (estimated)

## Conditions studied

- HIV
- Drug
- Resistance

## Interventions

- **DRUG:** Tenofovir Disoproxil

## Key facts

- **NCT ID:** NCT04453436
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-10
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2025-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04453436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04453436, "HIV Drug Resistance Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04453436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*